-
Enhancing Access to Meaningful Data: Nebraska Parkinson’s Disease Registry
… data for use in evaluating PD treatments and promoting PD research. Study Design: NPDR staff will onboard high volume … will promote increased data collection and use. Impact on Diagnosis/Treatment of Parkinson’s disease: Support of the … research. The NPDR will transform raw PD surveillance data into meaningful information to guide and evaluate efforts to …
-
Parkinson's Disease Progression Model
… Initiative provides a unique opportunity to gain insights into the progression of Parkinson's disease. By using this … patterns in cohorts of patients to provide new insights into the disease. Hypothesis: Using all components of the … further gather input from subject matter experts. Impact on Diagnosis/Treatment of Parkinson's Disease: Understanding …
-
Antibodies Blocking Alpha-synuclein Toxicity and Spread for the Treatment of Parkinson’s Disease
… Study Design: In this study, we will use a viral vector, a research tool that makes cells produce miniature proteins … clumps and destroy them. Our viral vector will be injected into the spinal canal inside the spinal cord, where the … and resulting motor symptoms of PD. Impact on Diagnosis/Treatment of Parkinson’s Disease: This study will …
-
Nebraska Parkinson's Disease Registry
… (APDA) and The Michael J. Fox Foundation for Parkinson's Research (MJFF) are co-funding the Nebraska Parkinson's … (suspended in October 2004 for budgetary reasons), allowing researchers to collect data with accurate, historical and … for research purposes. The Registry collected data from early 1997 until its suspension in October, 2004. The Act …
-
Gremlin-1, a Putative VTA-derived Neuroprotective Factor in Parkinson's Disease (Supplement)
… This grant builds upon the research from a prior grant: Gremlin-1, a Putative … with tamoxifen appeared healthy and their number was nearly identical to those in control models. Objectives for … priority. We will therefore infuse Gremlin by Alzet pump into the SN at various times following MPTP damage and test …
-
Bay Area Solvent Study - Symptoms (BASS-S)
… lower striatal dopamine transporter binding. Relevance to Diagnosis/Treatment of Parkinson’s … of chlorinated solvents in PD risk may allow for earlier diagnosis and treatment of PD, as well as the possibility of … at risk for PD extends beyond the occupational setting and into the home. This work will lay the foundation for a study …